Early genetic alterations in normal-looking cells at various distance from primary tumors can help detect the changes along the lining of mammary ducts that can lead to disease.
The findings of the multidisciplinary team of surgeons, pathologists and scientists led by principal investigator Dr. Susan Done are published inNature Communications.
Breast Cancer Management: Advances
The crab that invades the breast is no more a fear factor with all the advancements that medical science and customized protocols can fight breast cancer. the recent developments in the management of breast cancer.
Advertisement
‘Ductoscopy technique enables the pathologists to identify the exact duct in the breast leading to the tumor and subsequently classify genetic alterations that indicate cancer.’
Tweet it Now
Dr. Done, a pathologist affiliated with The Campbell Family Institute for Breast Cancer Research at Princess Margaret Cancer Centre, University Health Network, is also an associate professor in the Department of Laboratory Medicine and Pathobiology, University of Toronto.
"We have found another piece in the cancer puzzle - knowledge that could one day be used for more precision in screening and breast cancer prevention, and also help with therapeutic approaches to block some of the earliest alterations before cancer develops and starts to spread."
![Inflammatory Breast Cancer]( "Inflammatory Breast Cancer")
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.
Lead author Moustafa Abdalla writes: "Almost all genomic studies of breast cancer have focused on well-established tumors because it is technically challenging to study the earliest mutational events occurring in human breast epithelial cells." Instead, this study found a way to identify early changes that preceded the tumour, enabling better understanding of cancer biology and disease development.
"Normal breast epithelium from the duct giving rise to a breast cancer has not been previously studied in this way."
Dr. Done explains: "Most breast cancer starts in the epithelial cells lining the mammary ducts. But the breast ducts are complex structures, like the branches of a tree. Guesstimating which duct is close to the tumor is not very accurate. Thanks to our surgeons, we were able to obtain samples along normal-looking ducts close to the nipple and close to the tumor, as well as samples on the opposite side of the same breast to study and compare."
In the operating room, surgeons inserted a fibre-optic scope through the nipple into the ducts below, and then injected dye into cancerous breasts being removed. This ductoscopy technique enabled the pathologists to identify the exact duct leading to the tumor and subsequently classify genetic alterations either increasing or decreasing as they moved nearer to the cancer.
"Cancer is not a switch that happens overnight. Once a patient notices a lump the tumor has been present for some time accumulating genetic changes. It is difficult at that point to identify the first changes that may have had a role in initiating or starting the cancer," says Dr. Done.
The research further identified genes that seem to be acting together in groups or pathways. "Some of these genes were either increased or decreased in the area of the tumor, no matter the type of breast cancer, and this is important because within the patterns we identified were predictable alterations. This meant we could determine from the sample where it came from in the breast," says Dr. Done.
"Our research demonstrated and supports earlier research from elsewhere that changes in cells occur before you can see them. The fact that changes are already present in different regions of the breast could be important in the delivery of radiation therapy or surgical margin assessment. We're a long way from bringing this into clinic, but it is something we will think about as we continue our research."
Source: Eurekalert
Inflammatory Breast Cancer
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.
Advertisement
Lead author Moustafa Abdalla writes: "Almost all genomic studies of breast cancer have focused on well-established tumors because it is technically challenging to study the earliest mutational events occurring in human breast epithelial cells." Instead, this study found a way to identify early changes that preceded the tumour, enabling better understanding of cancer biology and disease development.
"Normal breast epithelium from the duct giving rise to a breast cancer has not been previously studied in this way."
Dr. Done explains: "Most breast cancer starts in the epithelial cells lining the mammary ducts. But the breast ducts are complex structures, like the branches of a tree. Guesstimating which duct is close to the tumor is not very accurate. Thanks to our surgeons, we were able to obtain samples along normal-looking ducts close to the nipple and close to the tumor, as well as samples on the opposite side of the same breast to study and compare."
In the operating room, surgeons inserted a fibre-optic scope through the nipple into the ducts below, and then injected dye into cancerous breasts being removed. This ductoscopy technique enabled the pathologists to identify the exact duct leading to the tumor and subsequently classify genetic alterations either increasing or decreasing as they moved nearer to the cancer.
"Cancer is not a switch that happens overnight. Once a patient notices a lump the tumor has been present for some time accumulating genetic changes. It is difficult at that point to identify the first changes that may have had a role in initiating or starting the cancer," says Dr. Done.
The research further identified genes that seem to be acting together in groups or pathways. "Some of these genes were either increased or decreased in the area of the tumor, no matter the type of breast cancer, and this is important because within the patterns we identified were predictable alterations. This meant we could determine from the sample where it came from in the breast," says Dr. Done.
"Our research demonstrated and supports earlier research from elsewhere that changes in cells occur before you can see them. The fact that changes are already present in different regions of the breast could be important in the delivery of radiation therapy or surgical margin assessment. We're a long way from bringing this into clinic, but it is something we will think about as we continue our research."
Source: Eurekalert
Screening for Breast Cancer with Clinical Breast Examination
Clinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography.
Advertisement
 Triple-Negative Breast CancerTriple-negative breast cancers are ER negative, PR negative, and lack overexpression of HER-2. They are difficult to treat and are very aggressive. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable